Deep Brain Stimulation (Model 7438 Therapy Controller)
DeviceDeep brain stimulation (DBS) is a surgical procedure used to treat a variety of disabling neurological symptoms
Other names: Model 7438 Therapy Controller
NCT Number: NCT01334814
The proposed study is a randomized, single blind trial of intermittent versus continuous stimulation among essential tremor (ET) patients with a chronic history of continuous stimulation.
Looking for future studies?
Notify Me50 year–80 year
All sexes
Interventional
Not applicable
The proposed study is a randomized, single blind trial of intermittent versus continuous stimulation among essential tremor (ET) patients with a chronic history of continuous stimulation. The trial is 10 weeks in length with clinical evaluations (about 60 minutes) performed on weeks 1, 2, 6, and 10, and phone interviews (about 5 minutes) on weeks 3, 4, 5, 7, 8, and 9. The study includes outcome measures of tremor, stimulation-induced side effects, sleep quality, and voltage threshold for optimal tremor control and sustained side-effects.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Deep brain stimulation (DBS) is a surgical procedure used to treat a variety of disabling neurological symptoms
Other names: Model 7438 Therapy Controller
Time frame: 10 weeks
The trial is 10 weeks in length with clinical evaluations (about 60 minutes) performed on weeks 1, 2, 6, and 10, and phone interviews (about 5 minutes) on weeks 3, 4, 5, 7, 8, and 9.
Time frame: 10 weeks
Time frame: 10 weeks
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03027310
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06235190
Central Nervous System Diseases, Essential Tremor
Phoenix, Arizona, United States
View Trial DetailsNCT05842434
Basal Ganglia Diseases, Brain Diseases
Boca Raton, Florida, United States
View Trial DetailsNCT03760406
Central Nervous System Diseases, Essential Tremor
Bordeaux, France
View Trial Details